CN113545479A - Formula food and application thereof - Google Patents
Formula food and application thereof Download PDFInfo
- Publication number
- CN113545479A CN113545479A CN202110832605.7A CN202110832605A CN113545479A CN 113545479 A CN113545479 A CN 113545479A CN 202110832605 A CN202110832605 A CN 202110832605A CN 113545479 A CN113545479 A CN 113545479A
- Authority
- CN
- China
- Prior art keywords
- powder
- resistant dextrin
- formula
- mass ratio
- whey protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 65
- 239000000843 powder Substances 0.000 claims abstract description 125
- 229920001353 Dextrin Polymers 0.000 claims abstract description 69
- 239000004375 Dextrin Substances 0.000 claims abstract description 69
- 235000019425 dextrin Nutrition 0.000 claims abstract description 69
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 56
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 55
- 235000021119 whey protein Nutrition 0.000 claims abstract description 55
- 229920001202 Inulin Polymers 0.000 claims abstract description 30
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 30
- 229940029339 inulin Drugs 0.000 claims abstract description 30
- 229920002752 Konjac Polymers 0.000 claims abstract description 26
- 235000010485 konjac Nutrition 0.000 claims abstract description 26
- 244000247812 Amorphophallus rivieri Species 0.000 claims abstract description 24
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims abstract description 24
- 239000000252 konjac Substances 0.000 claims abstract description 24
- 244000013123 dwarf bean Species 0.000 claims abstract description 19
- 235000021278 navy bean Nutrition 0.000 claims abstract description 19
- 235000019871 vegetable fat Nutrition 0.000 claims description 24
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 22
- 235000010755 mineral Nutrition 0.000 claims description 22
- 239000011707 mineral Substances 0.000 claims description 22
- 229940088594 vitamin Drugs 0.000 claims description 22
- 229930003231 vitamin Natural products 0.000 claims description 22
- 235000013343 vitamin Nutrition 0.000 claims description 22
- 239000011782 vitamin Substances 0.000 claims description 22
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 20
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 20
- 239000000811 xylitol Substances 0.000 claims description 20
- 235000010447 xylitol Nutrition 0.000 claims description 20
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 20
- 229960002675 xylitol Drugs 0.000 claims description 20
- 108010084695 Pea Proteins Proteins 0.000 claims description 19
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 19
- 235000019702 pea protein Nutrition 0.000 claims description 19
- 235000021537 Beetroot Nutrition 0.000 claims description 18
- 235000020971 citrus fruits Nutrition 0.000 claims description 18
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 15
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 15
- 239000001508 potassium citrate Substances 0.000 claims description 15
- 229960002635 potassium citrate Drugs 0.000 claims description 15
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 15
- 235000011082 potassium citrates Nutrition 0.000 claims description 15
- 239000001509 sodium citrate Substances 0.000 claims description 15
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 12
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 229910021555 Chromium Chloride Inorganic materials 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 4
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 4
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 4
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 claims description 4
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 4
- 239000001354 calcium citrate Substances 0.000 claims description 4
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 4
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 4
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 239000011773 ferrous fumarate Substances 0.000 claims description 4
- 235000002332 ferrous fumarate Nutrition 0.000 claims description 4
- 229960000225 ferrous fumarate Drugs 0.000 claims description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 4
- 239000001095 magnesium carbonate Substances 0.000 claims description 4
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 4
- 229940099596 manganese sulfate Drugs 0.000 claims description 4
- 239000011702 manganese sulphate Substances 0.000 claims description 4
- 235000007079 manganese sulphate Nutrition 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229960000342 retinol acetate Drugs 0.000 claims description 4
- 235000019173 retinyl acetate Nutrition 0.000 claims description 4
- 239000011770 retinyl acetate Substances 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 229940042585 tocopherol acetate Drugs 0.000 claims description 4
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 4
- 239000011647 vitamin D3 Substances 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- 239000002211 L-ascorbic acid Substances 0.000 claims description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 3
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 229960002079 calcium pantothenate Drugs 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229960002104 cyanocobalamin Drugs 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 235000020778 linoleic acid Nutrition 0.000 claims description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 3
- 235000019175 phylloquinone Nutrition 0.000 claims description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- 229960001898 phytomenadione Drugs 0.000 claims description 3
- 235000007715 potassium iodide Nutrition 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- 229960001790 sodium citrate Drugs 0.000 claims description 3
- 235000011083 sodium citrates Nutrition 0.000 claims description 3
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 235000014692 zinc oxide Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 235000016709 nutrition Nutrition 0.000 abstract description 18
- 230000035764 nutrition Effects 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 230000003187 abdominal effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 description 48
- 238000000034 method Methods 0.000 description 39
- 238000002156 mixing Methods 0.000 description 39
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 230000001965 increasing effect Effects 0.000 description 19
- 239000000047 product Substances 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 208000008589 Obesity Diseases 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 238000011049 filling Methods 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 235000012907 honey Nutrition 0.000 description 9
- 238000004806 packaging method and process Methods 0.000 description 9
- 235000013944 peach juice Nutrition 0.000 description 9
- 238000007789 sealing Methods 0.000 description 9
- 244000046052 Phaseolus vulgaris Species 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000004580 weight loss Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000007012 clinical effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000014105 formulated food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000020888 liquid diet Nutrition 0.000 description 3
- 208000001022 morbid obesity Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011076 safety test Methods 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 240000008892 Helianthus tuberosus Species 0.000 description 2
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 108010060630 Lactoglobulins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 108010090785 inulinase Proteins 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 239000013585 weight reducing agent Substances 0.000 description 2
- 229940054810 white kidney bean extract Drugs 0.000 description 2
- 235000021241 α-lactalbumin Nutrition 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 241000729173 Cirsium japonicum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 1
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a formula food, which comprises the following components: the weight ratio of the concentrated whey protein to the resistant dextrin is 0.25-2:1, the weight ratio of the separated whey protein to the resistant dextrin is 0.1-1.8:1, the weight ratio of the konjac refined powder to the resistant dextrin is 0.15-1.8:1, the weight ratio of the inulin to the resistant dextrin is 0.15-1.8:1, and the weight ratio of the navy bean powder to the resistant dextrin is 0.05-1: 1. The formula food disclosed by the invention has no harm to a human body, can provide basic nutrition, has the effect of controlling weight, and can effectively control and reduce the indexes of waist circumference, abdominal circumference, weight and the like of obese people. Particularly, the nutritional powder can be used as a formula food for special medical purposes, is used for obese or fat-reducing operation crowds, can meet the special nutritional requirements of the obese or fat-reducing operation crowds as a single nutritional source, and can also be used as a daily nutritional supplement for the crowds needing fat reduction.
Description
Technical Field
The invention belongs to the technical field of food, and particularly relates to formula food and application thereof.
Background
Recent analysis from World Health Organization (WHO) Global Disease Burden (GDB) studies has shown that the worldwide obesity/overweight adult ratio has increased since 198028%, and 47% in children, obesity has become one of the rapidly growing public health problems worldwide. For example, in the United states, the incidence rate of adult obesity reaches 34%, the incidence rate of juvenile obesity is 17%, and the incidence rate is doubled compared with that in 1994. Meanwhile, the American severe obesity (namely the BMI is more than or equal to 40 Kg/m)2) The incidence rate also increased from 3.9% in 2000 to 6.6% in 2012. China also becomes the third-most obese population, accounting for 15% of the global obese population with india. According to the survey results published in reports of nutrition and chronic disease states of Chinese residents (2015), the prevalence rate of obesity of adults over 18 years old in China is increased from 4.5% (2002) to 9.6% (2012) in ten years, and meanwhile, the obesity rate of teenagers of children 6-17 years old is increased by 2.05 times and reaches 6.4% (2.1%, 2002).
With the increasing of the prevalence rate of obesity year by year, a series of complications caused by obesity are increasingly prominent, such as diabetes, hypertension, hyperlipidemia, coronary heart disease, cerebral apoplexy, breast cancer and other diseases, researches show that the harm caused by obesity complications can be reduced by reducing the body weight by 3-5%, and therefore the weight reduction requirement can be met through diet-exercise-behavior comprehensive intervention. However, for the patient population with severe obesity or with cardiovascular complications, the above therapies have failed to achieve the need for weight loss, but rather the goal of weight loss through either pharmaceutical or surgical treatment.
The therapeutic operation of severe obesity is a recommended surgical treatment that can remove the disease and prolong the life of obese patients, but may also increase the nutrient consumption, and chronic nutrient deficiency and various complications after the bariatric operation are also of concern, so that patients after the bariatric operation should be regularly monitored and good dietary habits established to prevent or alleviate the complications. At present, in regard to nutrition management in the perioperative period of the weight-reducing operation, recommendable opinions are given by experts, for example, low-energy liquid diet is started 4 weeks before the operation is built by surgical experts, the weight of the patient is reduced by 5% -10%, the method can enable the patient to adapt to the liquid diet after the operation in an early stage, the content of fat in the abdomen can be reduced, fatty liver can be reduced, the operation difficulty can be reduced, complications can be reduced, and the number of hospitalization days can be shortened. There is no consensus on dietary recommendations after surgery, and many experts believe that a low energy liquid diet should be selected within 4 weeks after surgery. At present, the special medical food in domestic market is mainly full-nutrition powder, no related special medical products exist for specific diseases such as obesity and fat-reducing surgery, and the existing composition product or full-nutrition formula food cannot serve as a single source to meet the nutritional requirements of patients.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides a formula food and application thereof.
Specifically, the present invention relates to the following aspects:
1. a formula, wherein the formula comprises: the weight ratio of the concentrated whey protein to the resistant dextrin is 0.25-2:1, the weight ratio of the separated whey protein to the resistant dextrin is 0.1-1.8:1, the weight ratio of the konjac refined powder to the resistant dextrin is 0.15-1.8:1, the weight ratio of the inulin to the resistant dextrin is 0.15-1.8:1, and the weight ratio of the navy bean powder to the resistant dextrin is 0.05-1: 1.
2. The formula of claim 1, further comprising xylitol, isomaltooligosaccharide, vegetable fat powder, and pea protein, wherein the mass ratio of xylitol to resistant dextrin is 0.15-1.8:1, the mass ratio of isomaltooligosaccharide to resistant dextrin is 0.15-1.8:1, the mass ratio of vegetable fat powder to resistant dextrin is 1-3:1, and the mass ratio of pea protein to resistant dextrin is 0.025-0.35: 1.
3. The formula food according to the item 2, characterized in that the formula food further comprises juicy peach fruit powder, red beet powder, citrus fruit powder, minerals and vitamins, wherein the mass ratio of the juicy peach fruit powder to the resistant dextrin is 0.025-0.45:1, the mass ratio of the red beet powder to the resistant dextrin is 0.005-0.15:1, the mass ratio of the citrus fruit powder to the resistant dextrin is 0.001-0.018:1, the mass ratio of the minerals to the resistant dextrin is 0.07-0.22:1, and the mass ratio of the vitamins to the resistant dextrin is 0.01-0.036: 1.
4. The formula of claim 1, wherein the formula further comprises sodium citrate, potassium citrate, disodium hydrogen phosphate, and dipotassium hydrogen phosphate.
5. The formula of claim 1, wherein the formula comprises resistant dextrin, concentrated whey protein, whey protein isolate, konjac powder, inulin, navy bean powder, xylitol, isomalto-oligosaccharide, vegetable fat powder, pea protein, juicy peach fruit powder, red beet powder, citrus fruit powder, minerals, vitamins, sodium citrate, potassium citrate, disodium hydrogen phosphate and dipotassium hydrogen phosphate.
6. The formula of claim 1, wherein the vitamin is selected from the group consisting of retinyl acetate and vitamin D3One or more of dl-alpha-tocopherol acetate, vitamin K1, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, folic acid, calcium pantothenate, L-ascorbic acid, and biotin.
7. The formula of item 1, wherein the minerals are selected from one or more of calcium citrate, magnesium carbonate, ferrous fumarate, zinc oxide, copper sulfate, manganese sulfate, sodium selenite, potassium iodide, and chromium chloride.
8. The formula food according to item 1, wherein the total fat content in the vegetable fat powder is 49% -54%, the linolenic acid content is not less than 1.2%, and the linoleic acid content is not less than 12%.
9. Use of a formula according to any one of claims 1 to 8 for the preparation of a formula for specific medical use.
10. The use according to claim 9, wherein the special medical use formula is for use in weight loss or fat reduction surgery people.
The formula food disclosed by the invention has no harm to a human body, can provide basic nutrition, has the effect of controlling weight, and can effectively control and reduce the indexes of waist circumference, abdominal circumference, weight and the like of obese people. Particularly, the nutritional powder can be used as a formula food for special medical purposes, is used for obese or fat-reducing operation crowds, can meet the special nutritional requirements of the obese or fat-reducing operation crowds as a single nutritional source, and can also be used as a daily nutritional supplement for the crowds needing fat reduction.
Detailed Description
The present invention is further illustrated by the following examples, which are intended to be purely exemplary of the invention and are not intended to be limiting.
Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Although methods and materials similar or equivalent to those described herein can be used in experimental or practical applications, the materials and methods are described below. In case of conflict, the present specification, including definitions, will control, and the materials, methods, and examples are illustrative only and not intended to be limiting. The present invention is further illustrated by the following examples, which are not intended to limit the scope of the invention.
The invention provides a formula food, which comprises resistant dextrin, concentrated whey protein, separated whey protein, konjac powder, inulin and navy bean powder, wherein the mass ratio of the concentrated whey protein to the resistant dextrin is 0.25-2:1, the mass ratio of the separated whey protein to the resistant dextrin is 0.1-1.8:1, the mass ratio of the konjac powder to the resistant dextrin is 0.15-1.8:1, the mass ratio of the inulin to the resistant dextrin is 0.15-1.8:1, and the mass ratio of the navy bean powder to the resistant dextrin is 0.05-1: 1.
In a specific embodiment, the formula further comprises xylitol, isomaltooligosaccharide, vegetable fat powder and pea protein, wherein the mass ratio of the xylitol to the resistant dextrin is 0.15-1.8:1, the mass ratio of the isomaltooligosaccharide to the resistant dextrin is 0.15-1.8:1, the mass ratio of the vegetable fat powder to the resistant dextrin is 1-3:1, and the mass ratio of the pea protein to the resistant dextrin is 0.025-0.35: 1.
In a more preferred embodiment, the formula further comprises juicy peach fruit powder, red beet powder, citrus fruit powder, minerals, and vitamins, wherein the mass ratio of juicy peach fruit powder to resistant dextrin is 0.025-0.45:1, the mass ratio of red beet powder to resistant dextrin is 0.005-0.15:1, the mass ratio of citrus fruit powder to resistant dextrin is 0.001-0.018:1, the mass ratio of minerals to resistant dextrin is 0.07-0.22:1, and the mass ratio of vitamins to resistant dextrin is 0.01-0.036: 1.
Further, the formula may also include sodium citrate, potassium citrate, disodium hydrogen phosphate and dipotassium hydrogen phosphate.
In a particular embodiment, the formula comprises resistant dextrin, whey protein concentrate, whey protein isolate, konjac flour, inulin, navy bean flour, xylitol, isomalto-oligosaccharide, vegetable fat powder, pea protein, nectarine juice powder, red beet powder, citrus fruit powder, minerals, vitamins, sodium citrate, potassium citrate, disodium hydrogen phosphate and dipotassium hydrogen phosphate. The contents of the components are as described above.
The resistant dextrin is processed by starch, is a low-calorie glucan which is prepared by extracting and refining indigestible components of baked dextrin by using industrial technology, and belongs to low-molecular water-soluble dietary fiber. It has been shown by methylation analysis to have a more complex branched structure than the starting starch. It is presumed that these branched structures are formed by intramolecular dehydration of the reducing glucose terminal group contained in starch during thermal decomposition or transfer of the dissociated glucose residue to any hydroxyl group. The resistant dextrin has low calorie, heat resistance, acid resistance and freezing resistance, can be used as a low-calorie soluble food raw material, and has wide development prospect in the food industry.
Whey protein (known as protein king) is a protein extracted from milk, has the characteristics of high nutritional value, easy digestion and absorption, various active ingredients and the like, and is one of the accepted high-quality protein supplements for human bodies. First, among various proteins, the nutritional value of whey protein is the highest. In general, proteins having complete types and contents of essential amino acids and providing human needs can be called high-quality proteins, also called complete proteins. The whey protein belongs to high-quality complete protein and is also animal protein. It contains 8 kinds of amino acids essential for human body, and has reasonable proportion and human body requirement ratio, and is essential matter for human body growth, development, senility resisting and other life activities. Secondly, whey protein is easier to digest and absorb, and the milk contains 60% of whey protein and 40% of casein, so that the feces of the infants who drink the breast milk are softer and less in amount. In addition, whey is rich in cysteine and methionine, which maintain antioxidant levels in humans. Many experimental studies have also demonstrated that administration of whey protein concentrates can promote humoral and cellular immunity, stimulate the immune system of the human body, and prevent the development of chemically induced cancers. Therefore, the whey protein is a very good protein for enhancing immunity. Thirdly, whey protein is low in fat and lactose, but it contains beta-lactoglobulin, alpha-lactalbumin, immunoglobulin, and other active ingredients. It is these active ingredients that provide whey protein with many health benefits to the human body and therefore it is considered to be one of the high quality protein sources required by the human body. Concentrated whey protein is a soluble product obtained by concentrating whey protein, and is usually concentrated by ultrafiltration. The concentrated whey protein retains the native form of the protein and is almost free of milk fat.
The separated whey protein is high-purity whey protein obtained by further process treatment on the basis of concentrated whey protein, and the purity can reach more than 90%. It is expensive, 2-3 times as expensive as concentrated whey protein, but it is also more easily digested and absorbed. The true wonderful aspect of whey protein isolate lies in its nutritional value, which possesses high levels of high quality protein, which can provide desirable high quality protein to certain specifically desired populations such as infants and hospitalized patients. In addition, isolated whey proteins contain bioactive compounds such as: the alpha-lactalbumin, beta-lactoglobulin, lactoferrin and immunoglobulin can regulate the immunity of human bodies. Meanwhile, the separated whey protein also contains a large amount of BCAA (branched chain amino acid), so that nutrients required by muscles can be effectively supplemented, meanwhile, the oligophlin is also a precursor for producing antibodies in vivo, and is a nutritional supplement which is most suitable for increasing muscle growth and recovering health of patients at present.
The refined konjak flour is made up by using underground konjak tuber through a certain preparation process, and has the functions of reducing weight, building body, curing diseases and resisting cancer, etc.. The rhizoma Amorphophalli refined powder is soluble dietary fiber, and can form a protective layer around food to prevent digestive enzyme from acting on food. The konjac fine powder can absorb water to swell (80-100 times) in water, can suppress appetite, produces satiety and reduces the food intake. The rhizoma Amorphophalli refined powder can delay and prevent absorption of nutrient substances such as cholesterol and monosaccharide, thereby reducing synthesis of lipid and acid in vivo. The rhizoma Amorphophalli refined powder has effects of loosening bowel, relieving constipation, and increasing defecation amount, so it has effect of cleaning intestinal tract.
Inulin is a reserve polysaccharide in plants, mainly comes from plants, and has been found in 36000 kinds, including 11 families of dicotyledonous plants such as Compositae, Campanulaceae and Gentianaceae, and 11 families of monocotyledonous plants such as Liliaceae and gramineae. For example, inulin is abundant in Jerusalem artichoke, tubers of chicory, root tuber of Paeonia suffruticosa (Dali chrysanthemum), and roots of Cirsium japonicum, wherein inulin content of Jerusalem artichoke is the highest. Inulin is contained in the protoplast of a cell in a colloidal form, is easily dissolved in hot water unlike starch, is precipitated from water by adding ethanol, and does not react with iodine. Inulin is also very easily hydrolyzed to fructose under dilute acid, which is characteristic of all fructans. Can also be hydrolyzed into fructose by inulase (inulase). Enzymes that break down inulin are lacking in both humans and animals. Inulin is another energy storage form of plants except starch, is an ideal functional food ingredient, and is a good raw material for producing products such as fructo-oligosaccharide, polyfructose, high fructose syrup, crystalline fructose and the like.
Xylitol has a sweetness comparable to that of sucrose, absorbs a large amount of heat when dissolved in water, is one of all sugar alcohol sweeteners having the largest endothermic value, and therefore, when eaten in solid form, produces a pleasant cool feeling in the mouth. Xylitol can prevent dental caries. The metabolism is not regulated by insulin, and the product can be used as heat energy source for diabetes patients.
Isomaltooligosaccharides (IMO) are also called isomaltooligosaccharides, branched oligosaccharides, etc., and are designated as isomaltooligosaccharides according to the standard of the light industry in China. It is one kind of starch sugar, and has the main components of isomaltose, panose, isomaltotriose and oligosaccharide over tetrasaccharide with alpha-1, 6 glycosidic bond between glucose molecules. The additive is mainly applied to food, and can promote the reproduction of beneficial flora in human intestinal tract and help digestion and absorption.
White kidney beans are common edible beans in all countries in the world and are planted in all provinces and regions of China. The white kidney bean not only has rich nutritive value, but also has high medicinal and health-care values, and is a traditional medicinal and edible food in China. Modern scientific research shows that the white kidney bean extract contains high-activity alpha-amylase inhibiting substances, and the chemical components of the white kidney bean extract are composite glycoprotein which is called as 'starch blocker' abroad and means 'starch absorption blocker'. A white kidney bean essence product is developed in China, can inhibit the action of alpha-amylase, block starch decomposition and reduce glucose absorption, thereby having the effects of reducing postprandial blood sugar rise, reducing insulin secretion, reducing fat synthesis and the like, and can be effectively matched with diet therapy of diabetics and fat-reducing people to ensure that the diabetics are full of food and eliminate hunger sensation, but the postprandial blood sugar is not high and the weight is not increased.
The vegetable fat powder is a high and new technical product which is produced by taking high-quality vegetable oil, corn syrup, high-grade emulsifier, anticaking agent and the like as raw materials and adopting advanced process and equipment. It has good hydrophilicity, stability, ductility and special nutrition. Experiments show that because the vegetable fat has low cost and good food freshness, more and more food processing industry owners select the non-dairy creamer as the raw and auxiliary materials of the food, and the vegetable fat powder becomes the additive for the production of the food industry.
The pea protein powder is high-quality protein separated and extracted from peas by adopting an advanced process and a low-temperature low-pressure technology, contains eighteen amino acids necessary for human bodies, and belongs to complete-value protein.
Wherein the vitamin is selected from retinyl acetate and vitamin D3One or more of dl-alpha-tocopherol acetate, vitamin K1, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, folic acid, calcium pantothenate, L-ascorbic acid, and biotin.
In a specific embodiment, weight is givenThe vitamins comprise the following components in parts by weight: retinyl acetate 75-240 weight portions and vitamin D31.3-3.5 parts, 5500 parts of dl-alpha-tocopherol acetate 4000-.
The mineral is selected from one or more of calcium citrate, magnesium carbonate, ferrous fumarate, zinc oxide, copper sulfate, manganese sulfate, sodium selenite, potassium iodide, and chromium chloride.
In a specific embodiment, the minerals comprise, in parts by weight: 1790 portions of calcium citrate 1333, 273 portions of magnesium carbonate 217, 5.47-7.90 portions of ferrous fumarate, 1.0-3.25 portions of zinc oxide, 0.75-0.92 portion of copper sulfate, 0.565-1.698 portion of manganese sulfate, 0.02713-0.04726 portions of sodium selenite, 0.04967-0.06535 portions of potassium iodide and 0.03049-0.05488 portions of chromium chloride.
In a specific embodiment, the total fat content in the vegetable fat powder is 49% -54%, the linolenic acid content is not less than 1.2%, and the linoleic acid content is not less than 12%.
The invention also provides application of the formula food in preparation of formula food for special medical application.
Further, the formula food for special medical application is used for people who have weight loss or fat reduction operations.
Examples
Example 1
The formula food is prepared according to the following steps:
1) taking the phase A: 16g of separated whey protein, 5g of concentrated whey protein, 2g of pea protein, 5g of navy bean powder and 20g of vegetable fat powder; phase B: 10g of resistant dextrin, 3g of konjac fine powder, 5g of inulin, 4g of xylitol and 3g of isomaltooligosaccharide; and C phase: 1g of honey peach juice powder, 0.1g of red beet powder, 0.02g of citrus fruit powder, 1.6g of mineral substances and 0.2g of vitamins; phase D: 0.777g of sodium citrate, 0.75g of potassium citrate, 0.47g of disodium hydrogen phosphate, 0.793g of dipotassium hydrogen phosphate and 4.89g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) And (3) performing equivalent incremental method on the C phase and the D phase in the step (2) (wherein the equivalent incremental method is as follows: taking a small amount of components and an equal amount of components with large amount, simultaneously placing the components in a mixing machine for uniformly mixing, adding the components with large amount and equal amount of the mixture for uniformly mixing, and increasing the times till the components with large amount are completely added) for uniformly mixing for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 2
The formula food is prepared according to the following steps:
1) taking the phase A: 17g of separated whey protein, 7g of concentrated whey protein, 2g of pea protein, 5g of navy bean powder and 28g of vegetable fat powder; phase B: 18g of resistant dextrin, 16g of konjac fine powder, 12g of inulin, 10g of xylitol and 16g of isomaltooligosaccharide; and C phase: 0.8g of honey peach juice powder, 1.2g of red beet powder, 0.16g of citrus fruit powder, 1.8g of mineral substances and 0.3g of vitamins; phase D: 0.887g of sodium citrate, 0.836g of potassium citrate, 0.506g of disodium hydrogen phosphate, 0.884g of dipotassium hydrogen phosphate and 5.35g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 3
The formula food is prepared according to the following steps:
1) taking the phase A: 4g of separated whey protein, 20g of concentrated whey protein, 1.5g of pea protein, 6g of white kidney bean powder and 30g of vegetable fat powder; phase B: 20g of resistant dextrin, 18g of konjac fine powder, 15g of inulin, 10g of xylitol and 18g of isomaltooligosaccharide; and C phase: 1.8g of honey peach juice powder, 1.5g of red beet powder, 0.18g of citrus fruit powder, 2.1g of mineral substances and 0.36g of vitamins; phase D: 0.952g of sodium citrate, 0.978g of potassium citrate, 0.573g of disodium hydrogen phosphate, 1.033g of dipotassium hydrogen phosphate and 5.96g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 4
The formula food is prepared according to the following steps:
1) taking the phase A: 13g of separated whey protein, 8g of concentrated whey protein, 1.5g of pea protein, 3g of navy bean powder and 22g of vegetable fat powder; phase B: 12g of resistant dextrin, 5g of konjac fine powder, 10g of inulin, 6g of xylitol and 5g of isomaltooligosaccharide; and C phase: 1g of honey peach juice powder, 0.2g of red beet powder, 0.04g of citrus fruit powder, 1.6g of mineral substances and 0.25g of vitamins; phase D: 0.788g of sodium citrate, 0.822g of potassium citrate, 0.492g of disodium hydrogen phosphate, 0.869g of dipotassium hydrogen phosphate and 5.06g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 5
The formula food is prepared according to the following steps:
1) taking the phase A: 16g of separated whey protein, 10g of concentrated whey protein, 2g of pea protein, 4g of white kidney bean powder and 23g of vegetable fat powder; phase B: 14g of resistant dextrin, 9g of konjac fine powder, 11g of inulin, 8g of xylitol and 10g of isomaltooligosaccharide; and C phase: 1.5g of honey peach juice powder, 0.5g of red beet powder, 0.08g of citrus fruit powder, 1.8g of mineral substances and 0.26g of vitamins; phase D: 0.898g of sodium citrate, 0.878g of potassium citrate, 0.478g of disodium hydrogen phosphate, 0.923g of dipotassium hydrogen phosphate and 5.16g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 6
The formula food is prepared according to the following steps:
1) taking the phase A: 6g of separated whey protein, 15g of concentrated whey protein, 2.5g of pea protein, 7g of navy bean powder and 26g of vegetable fat powder; phase B: 18g of resistant dextrin, 15g of konjac fine powder, 13g of inulin, 12g of xylitol and 15g of isomaltooligosaccharide; and C phase: 2g of honey peach juice powder, 1g of red beet powder, 0.12g of citrus fruit powder, 2.1g of mineral substances and 0.32g of vitamins; phase D: 0.869g of sodium citrate, 0.808g of potassium citrate, 0.478g of disodium hydrogen phosphate, 0.854g of dipotassium hydrogen phosphate and 5.03g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 7
The formula food is prepared according to the following steps:
1) taking the phase A: 8g of separated whey protein, 10g of concentrated whey protein, 2g of pea protein, 4g of white kidney bean powder and 23g of vegetable fat powder; phase B: 13g of resistant dextrin, 8g of konjac fine powder, 8g of inulin, 8g of xylitol and 8g of isomaltooligosaccharide; and C phase: 2g of honey peach juice powder, 0.3g of red beet powder, 0.1g of citrus fruit powder, 1.8g of mineral substances and 0.3g of vitamins; phase D: 0.824g of sodium citrate, 0.808g of potassium citrate, 0.478g of disodium hydrogen phosphate, 0.854g of dipotassium hydrogen phosphate and 5.03g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 8
The formula food is prepared according to the following steps:
1) taking the phase A: 11g of separated whey protein, 12g of concentrated whey protein, 2g of pea protein, 5g of navy bean powder and 24g of vegetable fat powder; phase B: 14g of resistant dextrin, 9g of konjac fine powder, 8g of inulin, 10g of xylitol and 10g of isomaltooligosaccharide; and C phase: 2g of honey peach juice powder, 0.5g of red beet powder, 0.1g of citrus fruit powder, 1.8g of mineral substances and 0.3g of vitamins; phase D: 0.798g of sodium citrate, 0.833g of potassium citrate, 0.530g of disodium hydrogen phosphate, 0.881g of dipotassium hydrogen phosphate and 5.36g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Example 9
The formula food is prepared according to the following steps:
1) taking the phase A: 12g of separated whey protein, 13g of concentrated whey protein, 2g of pea protein, 4g of white kidney bean powder and 25g of vegetable fat powder; phase B: 15g of resistant dextrin, 11g of konjac fine powder, 8g of inulin, 8g of xylitol and 12g of isomaltooligosaccharide; and C phase: 2.5g of honey peach juice powder, 0.8g of red beet powder, 0.1g of citrus fruit powder, 1.8g of mineral substances and 0.3g of vitamins; phase D: 0.875g of sodium citrate, 0.0.883g of potassium citrate, 0.543g of disodium hydrogen phosphate, 0.934g of dipotassium hydrogen phosphate and 5.6g of citric acid.
2) Respectively and uniformly mixing the A, B, C, D four-phase raw materials in the step 1) for later use.
3) Mixing the C phase and the D phase in the step 2) uniformly according to an equivalent incremental method for later use.
4) And (3) fully and uniformly mixing the mixed raw materials in the step (3) and the phase B raw materials according to an equivalent incremental method for later use.
5) Uniformly mixing the mixed raw materials in the step 4) with the phase A raw materials according to an equivalent increasing method, filtering by a 80-mesh screen, immediately filling and sealing, packaging and inspecting to obtain the formula food.
Comparative example 1
Comparative example 1 differs from example 2 only in that the formula does not contain konjac flour.
Comparative example 2
Comparative example 2 differs from example 2 only in that the formula does not contain inulin.
Comparative example 3
Comparative example 3 differs from example 2 only in that the formula does not contain navy bean flour.
Comparative example 4
Comparative example 4 differs from example 2 only in that the formula does not contain resistant dextrin.
Test example 1 oral safety test for acute toxicity in animals
The formulated foods obtained in examples 1 to 9 and comparative examples 1 to 4 were subjected to an animal acute toxicity oral safety test.
1. Materials and methods
1.1 sample sources: the formulas of examples 1-9; animals: ICR mice, Beijing Wittiulihua laboratory animal technology Limited.
1.2 test methods: mice gavage acute toxicity experiment (maximum tolerance metering method), screening 90 mice each, and using LD50>The dosage of 80g/kg is orally gavaged, observed for 14 days, and observed indexes comprise animal activity, body weight, death rate and the like.
2. Results and analysis
The safety test results are as follows:
TABLE 1 evaluation of safety of formulated foods
As can be seen from Table 1, the oral acute toxicity of the 9 formula foods to mice of two sexes is more than 80g/kg, and the products are proved to be non-toxic according to the acute toxicity classification, thereby meeting the requirements of biological safety evaluation.
Test example 2 detection of Nutrition index
The formula foods in examples 1 to 6 were used for the detection of nutritional indicators, respectively, and the detection results were as follows:
TABLE 2 formula food nutrient component test results (per 100g)
The above table shows that the product of the invention meets the requirements of GB29922-2013 general rules of food safety national standard special medical application formula food on the nutritional indexes of the special medical application formula food, and can meet the normal physiological functions of specific people. In addition, the results of the above tests on the special medical-purpose total nutrient formula food provided in other embodiments are similar to the above results, and are not repeated.
Test example 3 clinical effects of formula food
The formula foods obtained in the examples 1 to 6 and the comparative examples 1 to 4 are subjected to clinical effect trial evaluation, 300 volunteers in the recovery period of obesity and fat reduction surgery (100 to 200 days after surgery) are gathered, the age is 20 to 50 years, the number of men and women is not limited, and 30 persons in each example participate in trial.
The test method comprises the following steps: the product of the invention is used as a single nutrition source, the trial period is 7 days, 3 times a day, and 65g of the product is taken each time; the taking method comprises the following steps: the volunteers took the medicine by infusing with 325ml warm boiled water (about 50 ℃) in the morning, at noon and at night every day, drinking water is not limited in the period, and the effect is counted after 7 days.
And (4) result judgment standard: the volunteer is judged to be effective when the weight of the volunteer is reduced or not obviously increased; volunteer weight gain was judged to be ineffective.
The results are as follows:
TABLE 3 clinical effects of formula foods
As can be seen from table 3, after the trial, the compositions 6 in the embodiments of the present invention are all formulated foods with special medical uses suitable for the obese and fat-reducing surgical population, and can meet the normal physiological functions of the population as a single-source food while controlling the weight gain. The compositions of comparative examples 1-4 are all weaker than those of examples 1-6, which shows that the resistant dextrin, the konjac powder, the inulin and the navy bean powder all affect the effect of the product of the invention, have the function of synergistic effect, and the lack of one of the resistant dextrin, the konjac powder, the inulin and the navy bean powder all affect the overall effect of the product. The reason for analyzing the dietary fiber can be that the konjac fine powder can inhibit appetite and generate satiety, the resistant dextrin has the low-calorie high satiety characteristic of the dietary fiber, the navy bean powder can block starch decomposition and reduce glucose absorption, and the inulin is combined to have the effect of regulating intestinal flora (researches show that obesity can be caused by intestinal flora imbalance) so as to achieve the purpose of controlling weight.
Test example 4 weight loss effect of formula food
The formula foods with special medical purposes obtained in the examples 1-6 and the comparative examples 1-4 are subjected to trial evaluation of weight loss effect, 300 obese volunteers with BMI more than 30.0 are gathered, the age is 20-50 years old, and the number of men and women is not limited, and 30 persons in each example participate in trial.
The test method comprises the following steps: the product of the invention is used as a nutritional supplement, the trial period is 60 days, 3 times a day, and 20g of the product is taken each time; the taking method comprises the following steps: the volunteers take the mixture with 100ml warm boiled water (about 50 ℃) in the morning, at noon and at night every day, during which no medicine is taken, the types and the amount of food are limited, and the effect is counted after 60 days. And (4) result judgment standard: the volunteer weight reduction is judged to be effective; volunteers were judged to be ineffective if there was no change or increase in weight.
The results are as follows:
TABLE 4 diet effect of formula foods
As can be seen from Table 4, the compositions of example 6 of the present invention all had weight loss efficacy after the trial. The compositions of comparative examples 1-4 are all weaker than those of examples 1-6, which shows that the resistant dextrin, the konjac powder, the inulin and the navy bean powder all affect the effect of the product of the invention, have the function of synergistic effect, and the lack of one of the components can affect the overall effect of the product.
Claims (10)
1. The formula food is characterized by comprising resistant dextrin, concentrated whey protein, separated whey protein, konjac powder, inulin and navy bean powder, wherein the mass ratio of the concentrated whey protein to the resistant dextrin is 0.25-2:1, the mass ratio of the separated whey protein to the resistant dextrin is 0.1-1.8:1, the mass ratio of the konjac powder to the resistant dextrin is 0.15-1.8:1, the mass ratio of the inulin to the resistant dextrin is 0.15-1.8:1, and the mass ratio of the navy bean powder to the resistant dextrin is 0.05-1: 1.
2. The formula according to claim 1, characterized in that the formula further comprises xylitol, isomaltooligosaccharide, vegetable fat powder and pea protein, wherein the mass ratio of xylitol to resistant dextrin is 0.15-1.8:1, the mass ratio of isomaltooligosaccharide to resistant dextrin is 0.15-1.8:1, the mass ratio of vegetable fat powder to resistant dextrin is 1-3:1, and the mass ratio of pea protein to resistant dextrin is 0.025-0.35: 1.
3. The formula of claim 2, further comprising juicy peach fruit powder, red beet powder, citrus fruit powder, minerals, and vitamins, wherein the mass ratio of juicy peach fruit powder to resistant dextrin is 0.025-0.45:1, the mass ratio of red beet powder to resistant dextrin is 0.005-0.15:1, the mass ratio of citrus fruit powder to resistant dextrin is 0.001-0.018:1, the mass ratio of minerals to resistant dextrin is 0.07-0.22:1, and the mass ratio of vitamins to resistant dextrin is 0.01-0.036: 1.
4. The formula of claim 1, wherein the formula further comprises sodium citrate, potassium citrate, disodium hydrogen phosphate, and dipotassium hydrogen phosphate.
5. The formula of claim 1, wherein the formula comprises resistant dextrin, whey protein concentrate, whey protein isolate, konjac flour, inulin, navy bean flour, xylitol, isomalto-oligosaccharide, vegetable fat powder, pea protein, juicy peach fruit powder, red beet powder, citrus fruit powder, minerals, vitamins, sodium citrate, potassium citrate, disodium hydrogen phosphate and dipotassium hydrogen phosphate.
6. The formula of claim 1, wherein the vitamin is selected from the group consisting of retinyl acetate and vitamin D3One or more of dl-alpha-tocopherol acetate, vitamin K1, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, folic acid, calcium pantothenate, L-ascorbic acid, and biotin.
7. The formula of claim 1, wherein the minerals are selected from one or more of calcium citrate, magnesium carbonate, ferrous fumarate, zinc oxide, copper sulfate, manganese sulfate, sodium selenite, potassium iodide, and chromium chloride.
8. The formula of claim 1, wherein the total fat content of the vegetable fat powder is 49% to 54%, the linolenic acid content is not less than 1.2%, and the linoleic acid content is not less than 12%.
9. Use of a formula according to any one of claims 1 to 8 for the preparation of a formula for specific medical use.
10. The use according to claim 9, wherein the food formulation for special medical use is intended for the people who undergo slimming or fat-reducing operations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110832605.7A CN113545479A (en) | 2021-07-22 | 2021-07-22 | Formula food and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110832605.7A CN113545479A (en) | 2021-07-22 | 2021-07-22 | Formula food and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113545479A true CN113545479A (en) | 2021-10-26 |
Family
ID=78104126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110832605.7A Pending CN113545479A (en) | 2021-07-22 | 2021-07-22 | Formula food and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113545479A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116195739A (en) * | 2023-04-19 | 2023-06-02 | 东南大学 | Diet for cleaning intestinal tract |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105380270A (en) * | 2015-11-26 | 2016-03-09 | 上海巅峰体育管理有限公司 | Nutritional meal replacement powder for weight losing |
| CN106880042A (en) * | 2017-01-18 | 2017-06-23 | 恩施硒域传奇健康管理有限公司 | A kind of full nutrition formula food suitable for fat, fat reducing patient with operation convalescence |
| CN107495355A (en) * | 2017-08-25 | 2017-12-22 | 江苏苏中健康产业有限公司 | A kind of fibrous type albumen meal replacement powder and preparation method thereof |
| CN109907115A (en) * | 2019-04-18 | 2019-06-21 | 明安旭(上海)健康科技有限公司 | A kind of composition and preparation method thereof lost weight and accelerate lipolysis |
| CN110638057A (en) * | 2019-10-15 | 2020-01-03 | 乐亭中肽生物科技有限公司 | Weight-losing meal replacement powder and preparation method thereof |
| CN111011691A (en) * | 2019-12-05 | 2020-04-17 | 陕西中鸿科瑞再生医学研究院有限公司 | High-protein high-fiber solid beverage |
| CN111053190A (en) * | 2019-12-26 | 2020-04-24 | 宁波御坊堂生物科技有限公司 | Light-weight food composition for weight-losing meal replacement and preparation method thereof |
| CN111543605A (en) * | 2020-06-03 | 2020-08-18 | 南通大学 | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity |
-
2021
- 2021-07-22 CN CN202110832605.7A patent/CN113545479A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105380270A (en) * | 2015-11-26 | 2016-03-09 | 上海巅峰体育管理有限公司 | Nutritional meal replacement powder for weight losing |
| CN106880042A (en) * | 2017-01-18 | 2017-06-23 | 恩施硒域传奇健康管理有限公司 | A kind of full nutrition formula food suitable for fat, fat reducing patient with operation convalescence |
| CN107495355A (en) * | 2017-08-25 | 2017-12-22 | 江苏苏中健康产业有限公司 | A kind of fibrous type albumen meal replacement powder and preparation method thereof |
| CN109907115A (en) * | 2019-04-18 | 2019-06-21 | 明安旭(上海)健康科技有限公司 | A kind of composition and preparation method thereof lost weight and accelerate lipolysis |
| CN110638057A (en) * | 2019-10-15 | 2020-01-03 | 乐亭中肽生物科技有限公司 | Weight-losing meal replacement powder and preparation method thereof |
| CN111011691A (en) * | 2019-12-05 | 2020-04-17 | 陕西中鸿科瑞再生医学研究院有限公司 | High-protein high-fiber solid beverage |
| CN111053190A (en) * | 2019-12-26 | 2020-04-24 | 宁波御坊堂生物科技有限公司 | Light-weight food composition for weight-losing meal replacement and preparation method thereof |
| CN111543605A (en) * | 2020-06-03 | 2020-08-18 | 南通大学 | Comprehensive nutrition powder for people with hypertension, hyperlipidemia and obesity |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116195739A (en) * | 2023-04-19 | 2023-06-02 | 东南大学 | Diet for cleaning intestinal tract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100450097B1 (en) | Compositions of plant carbohydrates as dietary supplements | |
| CN104431741B (en) | Cereal conditioning porridge and making method and application thereof | |
| CN102273585B (en) | Health-care porridge with effect of relaxing bowel and preparation method thereof | |
| CN108968085A (en) | A kind of dietary fiber meal replacement powder | |
| CN107087793A (en) | Mixture for the indigestible oligosaccharide of stimulating immune system | |
| CN106261439A (en) | Protein Diets fiber meal replacement powder and preparation method | |
| CN102511861A (en) | Thickened red jujube pulp added with oligosaccharide | |
| CN106387593A (en) | Protein dietary fiber solid beverage | |
| CN113017089A (en) | Meal replacement composition for improving basal metabolism level and preparation method and application thereof | |
| CN114403403B (en) | Jelly with fat and weight reducing effects and preparation method thereof | |
| CN102511864B (en) | Jujube high-consistency stock | |
| CN110192583A (en) | With the composition and application for promoting intestinal health, control weight and raising to be immunized | |
| CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
| CN112704237A (en) | Vegetable peptide fat-reducing composition and eating method thereof | |
| CN111771988A (en) | Nutritional food suitable for diabetic patients and preparation method thereof | |
| CN113545479A (en) | Formula food and application thereof | |
| CN104872775B (en) | A kind of compound fat-reducing solid beverage of green tea tea polysaccharide and application | |
| CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
| CN112167639A (en) | Composition for bidirectionally regulating morning-onset intestinal fluid balance, preparation method and application thereof | |
| CN106010920A (en) | Edible vinegar rich in prebiotics and preparation method thereof | |
| KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
| CN102048134A (en) | Five-material vegetable nutraceutical and preparation method thereof | |
| CN107712875A (en) | Black quinoa weight losing meal-replacing | |
| CN117715540A (en) | Infant formula for feeding infants receiving infant formula and human breast milk | |
| CN112690386A (en) | A dietetic composition with antioxidant and antibacterial effects and capable of enhancing cardiovascular and cerebrovascular and immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211026 |
|
| RJ01 | Rejection of invention patent application after publication |